TEVA PHARMACEUTICAL INDUSTRIES LIMITED Inventory
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Inventory of $3.22 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-07-29
- 2026-06-30: Inventory, Net $3.22B.
- 2026-03-31: Inventory, Net $3.18B.
- 2025-12-31: Inventory, Net $3.18B.
- 2025-09-30: Inventory, Net $3.32B.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $3.22B 10-Q · filed 2026-07-29 |
| 2026-03-31 | $3.18B 10-Q · filed 2026-04-29 |
| 2025-12-31 | $3.18B 10-Q · filed 2026-07-29 |
| 2025-09-30 | $3.32B 10-Q · filed 2025-11-05 |
| 2025-06-30 | $3.50B 10-Q · filed 2025-07-30 |
| 2025-03-31 | $3.25B 10-Q · filed 2025-05-07 |
| 2024-12-31 | $3.01B 10-K · filed 2026-02-03 |
| 2024-09-30 | $3.96B 10-Q · filed 2024-11-06 |
| 2024-06-30 | $3.93B 10-Q · filed 2024-07-31 |
| 2024-03-31 | $3.95B 10-Q · filed 2024-05-08 |
| 2023-12-31 | $4.02B 10-K · filed 2025-02-05 |
| 2023-09-30 | $4.05B 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.11B 10-Q · filed 2023-08-02 |
| 2023-03-31 | $4.12B 10-Q · filed 2023-05-10 |
| 2022-12-31 | $3.83B 10-K · filed 2024-02-12 |
| 2022-09-30 | $3.86B 10-Q · filed 2022-11-03 |
| 2022-06-30 | $4.05B 10-Q · filed 2022-07-27 |
| 2022-03-31 | $4.01B 10-Q · filed 2022-05-03 |
| 2021-12-31 | $3.82B 10-K · filed 2023-02-10 |
| 2021-09-30 | $4.17B 10-Q · filed 2021-10-27 |
| 2021-06-30 | $4.36B 10-Q · filed 2021-07-28 |
| 2021-03-31 | $4.41B 10-Q · filed 2021-04-28 |
| 2020-12-31 | $4.40B 10-K · filed 2022-02-09 |
| 2020-09-30 | $4.52B 10-Q · filed 2020-11-05 |
| 2020-06-30 | $4.36B 10-Q · filed 2020-08-05 |
| 2020-03-31 | $4.29B 10-Q · filed 2020-05-07 |
| 2019-12-31 | $4.42B 10-K · filed 2021-02-10 |
| 2019-09-30 | $4.64B 10-Q · filed 2019-11-07 |
| 2019-06-30 | $4.85B 10-Q · filed 2019-08-07 |
| 2019-03-31 | $4.78B 10-Q · filed 2019-05-02 |
| 2018-12-31 | $4.73B 10-K · filed 2020-02-21 |
| 2018-09-30 | $4.87B 10-Q · filed 2018-11-01 |
| 2018-06-30 | $4.97B 10-Q · filed 2018-08-02 |
| 2018-03-31 | $5.11B 10-Q · filed 2018-05-03 |
| 2017-12-31 | $4.92B 10-K · filed 2019-02-19 |
| 2017-09-30 | $5.06B 6-K · filed 2017-11-02 |
| 2017-06-30 | $5.13B 6-K · filed 2017-08-03 |
| 2017-03-31 | $5.00B 6-K · filed 2017-05-11 |
| 2016-12-31 | $4.95B 10-K · filed 2018-02-12 |
| 2016-09-30 | $5.35B 6-K · filed 2016-11-15 |
| 2016-06-30 | $3.92B 6-K · filed 2016-08-04 |
| 2016-03-31 | $3.96B 6-K · filed 2016-05-09 |
| 2015-12-31 | $3.97B 20-F · filed 2017-02-15 |
| 2015-09-30 | $4.09B 6-K · filed 2015-10-29 |
| 2015-06-30 | $4.23B 6-K · filed 2015-07-30 |
| 2015-03-31 | $4.17B 6-K · filed 2015-04-30 |
| 2014-12-31 | $4.37B 20-F · filed 2016-02-11 |
| 2014-09-30 | $4.59B 6-K · filed 2014-10-30 |
| 2014-06-30 | $4.94B 6-K · filed 2014-07-31 |
| 2014-03-31 | $4.98B 6-K · filed 2014-05-02 |
| 2013-12-31 | $5.05B 20-F · filed 2015-02-09 |
| 2013-09-30 | $5.24B 6-K · filed 2013-10-31 |
| 2013-06-30 | $5.33B 6-K · filed 2013-08-01 |
| 2013-03-31 | $5.38B 6-K · filed 2013-05-02 |
| 2012-12-31 | $5.50B 20-F · filed 2014-02-10 |
| 2012-09-30 | $5.46B 6-K · filed 2012-11-01 |
| 2012-06-30 | $5.29B 6-K · filed 2012-08-02 |
| 2012-03-31 | $5.33B 6-K · filed 2012-05-09 |
| 2011-12-31 | $5.01B 20-F · filed 2013-02-12 |
| 2011-09-30 | $4.67B 6-K · filed 2011-11-02 |
| 2011-06-30 | $4.46B 6-K · filed 2011-07-28 |
| 2011-03-31 | $4.22B 6-K · filed 2011-05-11 |
| 2010-12-31 | $3.87B 20-F · filed 2012-02-17 |
| 2010-09-30 | $3.86B 6-K · filed 2010-11-02 |
| 2010-06-30 | $3.08B 6-K · filed 2010-07-27 |
| 2010-03-31 | $3.24B 6-K · filed 2010-05-04 |
| 2009-12-31 | $3.33B 20-F · filed 2011-02-15 |
| 2009-09-30 | $3.45B 6-K · filed 2009-11-03 |
| 2009-06-30 | $3.50B 6-K · filed 2009-07-29 |
| 2009-03-31 | $3.21B 6-K · filed 2009-05-07 |
| 2008-12-31 | $3.40B 20-F · filed 2010-02-22 |